
The Lausanne startup, spun out of EPFL’s robotics lab, has deployed 15 pods across Switzerland and made its first international move with a unit in Toulouse. Its founder’s longer-term ambition: making commercial real estate itself modular and on-demand…

The Dutch biotech’s SureTACs platform targets membrane proteins that have long eluded conventional drug discovery by engineering them out of existence rather than blocking them. Biovance Capital joins as new co-lead alongside Kurma Partners in a final …